{
  "ticker": "NBIX",
  "success": true,
  "price": {
    "current": 135.79,
    "currency": "USD",
    "day_high": 137.075,
    "day_low": 134.88,
    "52_week_high": 160.18,
    "52_week_low": 84.23
  },
  "market_cap": {
    "value": 13539036160.0,
    "currency": "USD"
  },
  "shares_outstanding": 99705698.0,
  "volume": {
    "last": 1419297,
    "average_30d": 1085504
  },
  "valuation": {
    "pe_ratio": 32.33095,
    "forward_pe": 14.856332,
    "price_to_book": 4.507402
  },
  "company_info": {
    "name": "Neurocrine Biosciences, Inc.",
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Specialty & Generic"
  },
  "data_quality": {
    "flags": [],
    "has_price": true,
    "has_market_cap": true,
    "has_volume": true
  },
  "provenance": {
    "source": "Yahoo Finance via yfinance",
    "timestamp": "2026-01-12T09:16:53.949072",
    "url": "https://finance.yahoo.com/quote/NBIX",
    "data_hash": "bd9ddbbe3b86ccc7"
  }
}